Table 3.
The prevalence of COVID-19 within patients presenting with defined symptoms, contrasted against the percentage of those who experience these symptoms, all matched to the appropriate sample type to test for the disease [42,77].
| Examination or Sample Type |
Symptom(s) Associated with Choosing This Sample Type |
Number of Studies | Number of People Sampled |
% Prevalence of COVID-19 in Sampled Patients with Associated Symptoms |
% Prevalence of Symptoms in the General Public Reporting to Be COVID-19 Positive |
|---|---|---|---|---|---|
| Chest-CT scan | Dry Cough | 136 | 17,380 | 58 | 69.15 |
| Chest Pain | 30 | 3510 | 7 | N/A | |
| Bronchoalveolar lavage | Haemoptysis | 21 | 4698 | 2 | 0.48 |
| Sputum | Productive Cough | 136 | 17,380 | 58 | 27.88 |
| Faeces | Diarrhoea | 93 | 11,707 | 10 | 9.96 |
| Oral throat wash, nasopharyngeal swab and oropharyngeal swab |
Sore Throat | 78 | 11,721 | 12 | 9.55 |
| Runny Nose | 36 | 10,656 | 8 | N/A | |
| Nasal Congestion | 10 | 2584 | 5 | 3.36 | |
| Conjunctivital secretions | Conjunctivitis | 9 | 2715 | 2 | 0.55 |